Literature DB >> 19595511

Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome.

QiQi Zhou1, Buyi Zhang, G Nicholas Verne.   

Abstract

Irritable bowel syndrome (IBS) is a common gastrointestinal disorder in which the underlying pathophysiology is poorly understood; however, increased intestinal permeability in diarrhea-predominant IBS patients has been reported. Here we demonstrate that diarrhea-predominant IBS (D-IBS) patients display increased intestinal permeability. We have also found that increased intestinal membrane permeability is associated with visceral and thermal hypersensitivity in this subset of D-IBS patients. We evaluated 54 D-IBS patients and 22 controls for intestinal membrane permeability using the lactulose/mannitol method. All subjects ingested 5g of lactulose and 2g of mannitol in 100ml of water after which their urine was collected. We also evaluated the mean mechanical visual analogue scale (M-VAS) pain rating to nociceptive thermal and visceral stimulation in all subjects. All study participants also completed the FBDSI scale. Approximately 39% of diarrhea-predominant IBS patients had increased intestinal membrane permeability as measured by the lactulose/mannitol ratio. These IBS patients also demonstrated higher M-VAS pain intensity reading scale. Interestingly, the IBS patients with hypersensitivity and increased intestinal permeability had a higher FBDSI score (100.8 + or - 5.4) than IBS patients with normal membrane permeability and sensitivity (51.6 + or - 12.7) and controls (6.1 + or - 5.6) (p<0.001). A subset of D-IBS patients had increased intestinal membrane permeability that was associated with an increased FBDSI score and increased hypersensitivity to visceral and thermal nociceptive pain stimuli. Thus, increased intestinal membrane permeability in D-IBS patients may lead to more severe IBS symptoms and hypersensitivity to somatic and visceral stimuli.

Entities:  

Mesh:

Year:  2009        PMID: 19595511      PMCID: PMC2763174          DOI: 10.1016/j.pain.2009.06.017

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  44 in total

Review 1.  Evidence for generalized hyperalgesia in temporomandibular disorders patients.

Authors:  Eleni Sarlani; Joel D Greenspan
Journal:  Pain       Date:  2003-04       Impact factor: 6.961

2.  Pain hypersensitivity in patients with functional gastrointestinal disorders: a gastrointestinal-specific defect or a general systemic condition?

Authors:  M Bouin; P Meunier; M Riberdy-Poitras; P Poitras
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

3.  Visceral and cutaneous hypersensitivity in Persian Gulf war veterans with chronic gastrointestinal symptoms.

Authors:  Rebecca C Dunphy; Lee Bridgewater; Donald D Price; Michael E Robinson; Charles J Zeilman; G Nicholas Verne
Journal:  Pain       Date:  2003-03       Impact factor: 6.961

4.  A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development.

Authors:  E D Al-Chaer; M Kawasaki; P J Pasricha
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

5.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 6.  Irritable bowel syndrome as a common precipitant of central sensitization.

Authors:  G Nicholas Verne; Donald D Price
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

7.  Patients with irritable bowel syndrome have greater pain tolerance than normal subjects.

Authors:  I J Cook; A van Eeden; S M Collins
Journal:  Gastroenterology       Date:  1987-10       Impact factor: 22.682

8.  Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome.

Authors:  G Nicholas Verne; Nathan C Himes; Michael E Robinson; Kaundinya S Gopinath; Richard W Briggs; Bruce Crosson; Donald D Price
Journal:  Pain       Date:  2003-05       Impact factor: 6.961

Review 9.  Postinfectious irritable bowel syndrome.

Authors:  Robin C Spiller
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

Review 10.  Evolving pathophysiologic models of functional gastrointestinal disorders.

Authors:  Emeran A Mayer; Stephen M Collins
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

View more
  131 in total

1.  Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.

Authors:  Archana S Rao; Michael Camilleri; Deborah J Eckert; Irene Busciglio; Duane D Burton; Michael Ryks; Banny S Wong; Jesse Lamsam; Ravinder Singh; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

2.  Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.

Authors:  Olga Bednarska; Susanna A Walter; Maite Casado-Bedmar; Magnus Ström; Eloísa Salvo-Romero; Maria Vicario; Emeran A Mayer; Åsa V Keita
Journal:  Gastroenterology       Date:  2017-07-13       Impact factor: 22.682

Review 3.  A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome.

Authors:  Adrienne Lenhart; William D Chey
Journal:  Adv Nutr       Date:  2017-07-14       Impact factor: 8.701

Review 4.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 5.  New insights into visceral hypersensitivity--clinical implications in IBS.

Authors:  QiQi Zhou; G Nicholas Verne
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06       Impact factor: 46.802

Review 6.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

Review 7.  An Overview and Proposed Research Framework for Studying Co-Occurring Mental- and Physical-Health Dysfunction.

Authors:  Sarah L Hagerty; Jarrod M Ellingson; Timothy B Helmuth; L Cinnamon Bidwell; Kent E Hutchison; Angela D Bryan
Journal:  Perspect Psychol Sci       Date:  2019-06-07

8.  Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome.

Authors:  Robert J Shulman; Monica E Jarrett; Kevin C Cain; Elizabeth K Broussard; Margaret M Heitkemper
Journal:  J Gastroenterol       Date:  2014-01-17       Impact factor: 7.527

9.  MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.

Authors:  QiQi Zhou; Wiley W Souba; Carlo M Croce; G Nicholas Verne
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

10.  Gut inflammation in chronic fatigue syndrome.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Nutr Metab (Lond)       Date:  2010-10-12       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.